A SMAD4-modulated gene profile predicts disease-free survival in stage II and III colorectal cancer.

Bryan C SzeglinChao WuMichael R MarcoHyun Sung ParkZeda ZhangBing ZhangJulio Garcia-AguilarR Daniel BeauchampX Steven ChenJ Joshua Smith

Published in: Cancer reports (Hoboken, N.J.) (2021)

A SMAD4-modulated gene expression profile identified high-risk stage II and III colorectal cancer patients, can predict disease-free survival, and has prognostic potential for stage II and III colorectal cancer patients.

Keyphrases

free survival
end stage renal disease
gene expression
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
epithelial mesenchymal transition
peritoneal dialysis
dna methylation
patient reported outcomes
transforming growth factor
copy number